摘要
<正>腹膜透析(peritoneal dialysis,PD)是终末期肾脏病的替代治疗方案之一,具有可以居家实施、节省医疗费用、早期存活率高、对血流动力学影响较小、保护残余肾功能等优势。迄今为止,全世界有超过272 000例PD患者,约占全球终末期肾脏病透析患者的11%~([1])。长期的PD,腹膜暴露在生物相容性较差的腹膜透析液及其降解产物中及受到尿毒症毒素、急慢性炎症等因素影响,导致结构和功能紊乱引起腹膜纤维化、超滤衰竭,
引文
1.Li PK,Chow KM,MW Van de Luijtgaarden,et al.Changes in the worldwide epidemiology of peritoneal dialysis.Nat Rev Nephrol,2017,13(2):90-103.
2.Krediet RT,Struijk DG.Peritoneal changes in patients on longterm peritoneal dialysis.Nat Rev Nephrol,2013,9(7):419-429.
3.Williams JD,Craig KJ,Topley N,et al.Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol,2002,13(2):470-479.
4.Taranu T,Florea L,Paduraru D,et al.Morphological changes of the peritoneal membrane in patients with long-term dialysis.Rom J Morphol Embryol,2014,55(3):927-932.
5.Kinashi H,Ito Y,Mizuno M,et al.TGF-beta1 promotes lymphangiogenesis during peritoneal fibrosis.J Am Soc Nephrol,2013,24(10):1627-1642.
6.Aroeira LS,Aguilera A,Sanchez-Tomero JA,et al.Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients:pathologic significance and potential therapeutic interventions.J Am Soc Nephrol,2007,18(7):2004-2013.
7.Margetts PJ,Kolb M,Galt T,et al.Gene transfer of transforming growth factor-beta1 to the rat peritoneum:effects on membrane function.J Am Soc Nephrol,2001,12(10):2029-2039.
8.Ha H,Yu MR,Lee HB.High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells.Kidney Int,2001,59(2):463-470.
9.Shih SC,Ju M,Liu N,et al.Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1:mechanism of pericyte-induced vascular survival in vivo.Proc Natl Acad Sci U S A,2003,100(26):15859-15864.
10.Massague J.How cells read TGF-beta signals.Nat Rev Mol Cell Biol,2000,1(3):169-178.
11.Yoshizawa H,Morishita Y,Watanabe M,et al.TGF-beta(1)-siRNA delivery with nanoparticles inhibits peritoneal fibrosis.Gene Ther,2015,22(4):333-340.
12.Duan WJ,Yu X,Huang XR,et al.Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro.Am J Pathol,2014,184(8):2275-2284.
13.Patel P,Sekiguchi Y,Oh KH,et al.Smad3-dependent andindependent pathways are involved in peritoneal membrane injury.Kidney Int,2010,77(4):319-328.
14.张红利,郝丽荣.TGF-β/Smad信号通路在腹膜纤维化发生、防治中的作用.医学综述,2013,19(7):1173-1175.
15.Sun Y,Zhu F,Yu X,et al.Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis.Am J Nephrol,2009,30(1):84-94.
16.Nie J,Hao W,Dou X,et al.Effects of Smad7 overexpression on peritoneal inflammation in a rat peritoneal dialysis model.Perit Dial Int,2007,27(5):580-588.
17.Guo H,Leung JC,Lam MF,et al.Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis.J Am Soc Nephrol,2007,18(10):2689-2703.
18.Nie J,Dou X,Hao W,et al.Smad7 gene transfer inhibits peritoneal fibrosis.Kidney Int,2007,72(11):1336-1344.
19.Liu Q,Zhang Y,Mao H,et al.A crosstalk between the Smad and JNK signaling in the TGF-beta-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells.PLo SOne,2012,7(2):e32009.
20.Zhu F,Li T,Qiu F,et al.Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats.Am J Pathol,2010,176(2):650-659.
21.Yang J,Zhu T,Liu X,et al.Heat shock protein 70 protects rat peritoneal mesothelial cells from advanced glycation end-products-induced epithelial-to-mesenchymal transition through mitogenactivated protein kinases/extracellular signal-regulated kinases and transforming growth factor-beta/Smad pathways.Mol Med Rep,2015,11(6):4473-4481.
22.Li S,Zhou Y,Fan J,et al.Heat shock protein 72 enhances autophagy as a protective mechanism in lipopolysaccharide-induced peritonitis in rats.Am J Pathol,2011,179(6):2822-2834.
23.Noh H,Ha H,Yu MR,et al.Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species.Perit Dial Int,2005,25(1):38-47.
24.Bozkurt D,Cetin P,Sipahi S,et al.The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.Perit Dial Int,2008,28 Suppl 5:S38-S42.
25.Sawada T,Ishii Y,Tojimbara T,et al.The ACE inhibitor,quinapril,ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice.Pharmacol Res,2002,46(6):505-510.
26.陈伊文,俞雨生.肾素-血管紧张素-醛固酮系统与腹膜透析.肾脏病与透析肾移植杂志,2011(3):280-284.
27.Ullian ME,Luttrell LM,Lee MH,et al.Stimulation of Cyclooxygenase 2 Expression in Rat Peritoneal Mesothelial Cells.Nephron Exp Nephrol,2014.
28.徐家云.黄芪注射液对血管紧张素Ⅱ诱导的大鼠腹膜纤维化的保护作用.郑州大学,2010.
29.Jing S,Kezhou Y,Hong Z,et al.Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients.Nephrology(Carlton),2010,15(1):27-32.
30.Evans I.An Overview of VEGF-Mediated Signal Transduction.Methods Mol Biol,2015,1332:91-120.
31.Aroeira LS,Lara-Pezzi E,Loureiro J,et al.Cyclooxygenase-2mediates dialysate-induced alterations of the peritoneal membrane.J Am Soc Nephrol,2009,20(3):582-592.
32.Kim M,Allen B,Korhonen EA,et al.Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation.J Clin Invest,2016,126(9):3511-3525.
33.Yuan J,Fang W,Lin A,et al.Angiopoietin-2/Tie2 signaling involved in TNF-alpha induced peritoneal angiogenesis.Int JArtif Organs,2012,35(9):655-662.
34.Zareie M,Hekking LH,Welten AG,et al.Contribution of lactate buffer,glucose and glucose degradation products to peritoneal injury in vivo.Nephrol Dial Transplant,2003,18(12):2629-2637.
